Key result
Composite valve grafts achieve ~72% ten-year survival and high freedom from reoperation in aortic disease.
Why the study?
The clinical outcomes of composite valve graft replacement in patients with aortic valve disease and ascending aorta aneurysm, including subgroups by Marfan syndrome and aortic dissection status, were evaluated to understand long-term results and technique impacts.
What are the long-term outcomes of composite valve graft replacement in patients with aortic valve disease and ascending aortic aneurysm?
Cohort (n=193)
What are the long-term outcomes of composite valve graft replacement in patients with aortic valve disease and ascending aortic aneurysm?
Composite valve graft replacement provides satisfactory long-term survival, though patients with Marfan syndrome or aortic dissection remain at higher risk for cardiovascular events and reoperation.
Answers are grounded in this paper and cite their sources.
Supports satisfactory long-term outcomes with composite valve graft replacement; leaves open optimal strategies in Marfan or dissection subgroups.
The purpose of this study was to evaluate the clinical outcome of composite valve graft replacement in 193 patients with aortic valve disease and aneurysm of the ascending aorta from January 1980 to June 1999. The clinical outcome was compared between the patients diagnosed with Marfan syndrome (M group) and those without Marfan syndrome (non-M group), between those with aortic dissection (AD group) and without dissection (non-AD group), between 2 different techniques for coronary artery reattachment (modified Bentall [mB] and modified Piehler [mP]), and between the time of operation (1980-1989 and 1990-1999). Long-term outcome of this procedure was almost satisfactory with actuarial survival of 71.5 +/- 4.4% at 10 years and freedom from reoperation of 76.5 +/- 4.4% at 10 years. Freedom from cardiovascular events and freedom from reoperation were significantly lower in the M group and AD group than in the non-M and non-AD groups. Also, actuarial survival was significantly higher in the latter 10 years compared with the former 10 years. It was concluded that the improvement of perioperative management and proper selection of the technique for coronary artery reattachment could have improved the clinical outcome. In patients with Marfan syndrome or aortic dissection, there still remains a higher risk of cardiovascular event and future reoperation. Extensive aortic reconstruction or staged operation should be performed in such patients.
No takes yet. Share an insight, caveat, or question.
Aomi et al. (2002) conducted a cohort in Aortic valve disease and aneurysm of the ascending aorta (n=193). Composite valve graft replacement was evaluated on Actuarial survival at 10 years. Composite valve graft replacement for aortic valve disease and ascending aortic aneurysm achieved a 10-year actuarial survival of 71.5% and freedom from reoperation of 76.5%.
Synapse has enriched 10 related papers. Consider them for comparative context: